Atrial fibrillation in heart failure: Prognostic significance and management

被引：30

作者：

Naccarelli, GV ^{[1
]}

Hynes, BJ

Wolbrette, DL

Bhatta, L

Khan, M

Samii, S

Luck, JC

机构：

[1] Penn State Univ, Coll Med, Div Cardiol, Hershey, PA 17033 USA

[2] Penn State Univ, Coll Med, Penn State Cardiovasc Ctr, Hershey, PA 17033 USA

来源：

JOURNAL OF CARDIOVASCULAR ELECTROPHYSIOLOGY | 2003年 / 14卷 / 12期

关键词：

atrial fibrillation; heart failure;

D O I：

10.1046/j.1540-8167.2003.90404.x

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

Atrial fibrillation and congestive heart failure are commonly occurring cardiac disorders that often exist concomitantly. The prognostic significance of the presence or absence of atrial fibrillation, as an independent risk factor, in patients with heart failure remains controversial. Antiarrhythmic drugs with good hemodynamic profiles and neutral effects on survival are preferred treatments for converting atrial fibrillation and maintaining sinus rhythm. Other standard therapies for congestive heart failure, such as angiotensin-converting enzyme inhibitors, angiotensin receptor blockers, and beta-blockers also have a role in the treatment of these coexisting disease states. The article presents an overview of atrial fibrillation in patients with heart failure and reviews the prevalence, prognostic significance, and efficacy of various antiarrhythmic agents for the conversion and maintenance of sinus rhythm.

引用

页码：S281 / S286

页数：6

共 76 条

[1] Cardiac resynchronization in chronic heart failure [J].

Abraham, WT ;

Fisher, WG ;

Smith, AL ;

Delurgio, DB ;

Leon, AR ;

Loh, E ;

Kocovic, DZ ;

Packer, M ;

Clavell, AL ;

Hayes, DL ;

Ellestad, M ;

Messenger, J ;

Trupp, RJ ;

Underwood, J ;

Pickering, F ;

Truex, C ;

McAtee, P .

NEW ENGLAND JOURNAL OF MEDICINE, 2002, 346 (24) :1845-1853

[2]

Allessie MA, 2001, CIRCULATION, V103, P769

[3]

[Anonymous], 1997, Eur Heart J, V18, P649

[4] Impact of atrial fibrillation on the risk of death [J].

Benjamin, EJ ;

Wolf, PA ;

D'Agostino, RB ;

Silbershatz, H ;

Kannel, WB ;

Levy, D .

CIRCULATION, 1998, 98 (10) :946-952

[5] Success of serial external electrical cardioversion of persistent atrial fibrillation in maintaining sinus rhythm - A randomized study [J].

Bertaglia, E ;

D'Este, D ;

Zerbo, F ;

Zoppo, F ;

Delise, P ;

Pascotto, P .

EUROPEAN HEART JOURNAL, 2002, 23 (19) :1522-1528

[6] Oral propafenone to convert recent-onset atrial fibrillation in patients with and without underlying heart disease - A randomized, controlled trial [J].

Boriani, G ;

Biffi, M ;

Capucci, A ;

Botto, GL ;

Broffoni, T ;

Rubino, I ;

DellaCasa, S ;

Sanguinetti, M ;

Magnani, B .

ANNALS OF INTERNAL MEDICINE, 1997, 126 (08) :621-625

[7] Assessment of atrioventricular junction ablation and VVIR pacemaker versus pharmacological treatment in patients with heart failure and chronic atrial fibrillation - A randomized, controlled study [J].

Brignole, M ;

Menozzi, C ;

Gianfranchi, L ;

Musso, G ;

Mureddu, R ;

Bottoni, N ;

Lolli, G .

CIRCULATION, 1998, 98 (10) :953-960

[8] The Azimilide post-infarct survival evaluation (ALIVE) trial [J].

Camm, AJ ;

Karam, R ;

Pratt, CM .

AMERICAN JOURNAL OF CARDIOLOGY, 1998, 81 (6A) :35D-39D

[9] Safety of oral propafenone in the conversion of recent onset atrial fibrillation to sinus rhythm: A prospective parallel placebo-controlled multicentre study [J].

Capucci, A ;

Villani, GQ ;

Aschieri, D ;

Piepoli, M .

INTERNATIONAL JOURNAL OF CARDIOLOGY, 1999, 68 (02) :187-196

[10]

CARSON PE, 1993, CIRCULATION, V87, P102

← 1 2 3 4 5 6 7 8 →